Member Society Symposia

Translational Immunology at the NIH: A Look at the Future

Wednesday, June 14
8:00 AM - 12:00 PM

Sponsored By: 

This session will focus on the future of the intramural NIH clinical immunology with an emphasis on highlighting young investigators that will shape the future of NIH immunology translational research.

Chair:
Behdad (Ben) Afzali, PhD; Howard Young, PhD

Agenda:
08:00 a.m. The Coming of Age of JAK inhibitors: From Targets to Treatment
Massimo Gadina, PhD, National Institutes of Health

08:30 a.m. An Immunodeficiency and Autoimmunity Disease Caused by Mutations in BACH2
Ben Afzali, PhD, National Institutes of Health

09:00 a.m. Altered Dendritic Cell Function in Autoimmune Diabetes
Kristin Tarbell, PhD, National Institutes of Health

09:30 a.m. IL-18 at the Intersection of Auto- and Hyper-Inflammation
Scott Canna, MD, National Institutes of Health

10:00 a.m. Coffee Break

10:15 a.m. Primary Biliary Cholangitis: the Dark Side of Interferon-Gamma
Howard Young, PhD, National Institutes of Health

10:45 a.m. Application of Heterodimeric IL-15 Cytokine in Cancer Immunotherapy
Cristina Bergamaschi, PhD, National Cancer Institute

11:15 a.m. Plenary lecture - The γc Family of Cytokines: Immunodeficiency, STAT Tetramerization, and the Fine-Tuning of Cytokine Signals
Warren Leonard, MD, National Institutes of Health

Learning Objectives:


Assets

Translational Immunology at the NIH: A Look at the Future



Attendees who have favorited this

Send Email for Translational Immunology at the NIH: A Look at the Future